EULAR is committed to advancing excellence in rheumatology through the promotion of task forces dedicated to developing evidence-based recommendations. In line with EULAR’s core principles of equality, diversity, and inclusion, we invite applications from qualified individuals to participate in these initiatives.

Members of EULAR task forces are experienced investigators in rheumatology, representing key areas of focus including Quality of Care and Clinical Affairs (QoC), Research (RES), Health Professionals in Rheumatology (HPR), and PARE (People with Arthritis and Rheumatism in Europe). 

Individuals from EULAR member societies who wish to apply are invited to submit a one-page letter of interest via the online link provided on this webpage. The letter should briefly outline the applicant’s relevant expertise and motivation for joining the task force. 

The final selection of candidates will be made by the task force convenor, in accordance with the EULAR Standard Operating Procedures (SOPs, section 3.1: Task Force Composition) and the principles of equality, diversity, and inclusion. 

Selection will be guided by the following criteria: 

• Demonstrated experience and publications in the relevant field, including participation in other task forces. 
• Representation from key academic centres active in the respective field across Europe. 
• Inclusion of a sufficient number of experts identified through publications or clinical work whose activities are not primarily industry-sponsored. 
• Comprehensive expertise covering all aspects of the disease relevant to the recommendation’s scope. 
• Balanced geographical representation.

Please note: 

the EMEUNET, HPR and PARE internal processes for the selection of their mandatory slots of representatives in the Task Forces are not related to this specific EULAR Task Forces wide general applications Call and are managed directly by these communities. 

To apply as task force member please go to the project dedicated application’s links below.

Deadline to apply: Monday 9 November 2026 at 23:45 hours (CET). 

Open calls

• QoC058 - Update of the EULAR recommendations for the Management of Psoriatic Arthrities with Pharmacological Therapies, Josef Smolen     
  
  Apply here 
  

• QoC057 - EULAR Points to Consider for the Definition of Undifferentiated Connective Tissue Disease (UCTD), Marta Mosca - Sarah Dyball
  
  Apply here 
  

• QoC056 - EULAR recommendations for the management of Sjögren’s disease with topical and systemic therapies: an update, Roberto Giacomelli - Athanasios Tzioufas
  
  Apply here
  
  
• QoC055 - EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis – 2026 Update, Peter Mandl - Philip Conaghan
  
  Apply here
  
  
• QoC054 - EULAR points to consider for the definition of difficult-to-manage systemic sclerosis, Muriel Elhai - Oliver Distler 
  
  Apply here
  
  

• QoC053 - IMPL – Implementing Brief Assessments and Interventions for Physical Activity and Sedentary Behaviour to Rheumatology Care, Anne Kathrin Rausch - Leti van Bodegom - Keegan Knittle
  
  Apply here
  
  
• QoC052 - Update of the 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases, Annette de Thurah - Christian Dejaco
  
  Apply here
  
  
• QoC051 - 2026 Update – EULAR Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis, Ingrid Larsson - Bente Appel Esbensen
  
  Apply here
  
  
• QoC050 - EULAR recommendations for the management of calcium pyrophosphate deposition disease, Giorgios Filippou - Tristan Pascart
  
  Apply here
  
  
• QoC049 - EULAR definition of treatment-refractory manifestations of Systemic lupus erythematosus, Maria Tektonidou
  
  Apply here